Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

6,262

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

6,262 results for “Treatment efficacy”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

ClinicalTrials.gov study NCT01826981. IPD Sharing: YES. Countries: 1. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Study Utilizing Patient-Reported and Radiographic Outcomes and Evaluating the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthriti

ClinicalTrials.gov study NCT03928184. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects

ClinicalTrials.gov study NCT01306617. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia

ClinicalTrials.gov study NCT01270828. IPD Sharing: Not stated. Countries: 17. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients

ClinicalTrials.gov study NCT00693654. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

ClinicalTrials.gov study NCT04377711. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

ClinicalTrials.gov study NCT04475432. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

ClinicalTrials.gov study NCT02670538. IPD Sharing: Not stated. Countries: 8. Publications: 6.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

ClinicalTrials.gov study NCT03895203. IPD Sharing: YES. Countries: 14. Publications: 15.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids

ClinicalTrials.gov study NCT02655237. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
dryad36/100

Data from: Modelling the potential efficacy of treatments for white-nose syndrome in bats

Open the record for dataset details and reuse information.

publicMar 2020View details →
dryad36/100

Dataset for: Efficacy of prescribed fire as a fuel reduction treatment in the Colorado Front Range

Open the record for dataset details and reuse information.

publicJan 2023View details →
zenodo32/100

A Cross-Sectional Odyssey: Unraveling Treatment Efficacy, Comorbid Impact, and Predictive Markers in Necrotizing Otitis Externa

<p>This study embarks on a comprehensive cross-sectional analysis to explore the multifaceted landscape of Necrotizing Otitis Externa (NOE). By evaluating the efficacy of diverse treatment regimens, the investigation reveals critical insights into the recovery rates, hospitalization durations, and recurrence rates associated with antibiotic monotherapy, combined antibiotic therapy, surgical intervention, and hyperbaric oxygen therapy. Additionally, the impact of comorbid conditions such as diabetes and immunocompromised states on clinical outcomes underscores the complexity of NOE management. Treatment complications, mortality rates, and hospitalization durations differ significantly among patients with varying comorbidities, as reflected by the ANOVA p-values. This odyssey also delves into the initial and final responses to treatment, offering predictive markers for clinical improvement and stability. The integration of these findings aims to enhance therapeutic strategies, providing a nuanced understanding of NOE and guiding clinicians towards optimized patient care.</p>

opencc-by-4.0Jun 2024View details →
zenodo32/100

Comparative Efficacy and Safety of Sitagliptin Phosphate Combined with Gliclazide Sustained-Release Tablets Versus Metformin in Treatment-Naïve Patients with Type 2 Diabetes Mellitus and Glucotoxicity: A Single-Center, Prospective, Randomized Controlled Non-Inferiority Study

<p>This dataset supports the manuscript titled "Comparative Efficacy and Safety of Sitagliptin Phosphate Combined with Gliclazide Sustained-Release Tablets Versus Metformin in Treatment-Na&iuml;ve Patients with Type 2 Diabetes Mellitus and Glucotoxicity: A Single-Center, Prospective, Randomized Controlled Non-Inferiority Study." The study aims to compare the efficacy and safety of sitagliptin phosphate combined with gliclazide sustained-release tablets against metformin in treatment-na&iuml;ve patients with type 2 diabetes mellitus and glucotoxicity. Data include clinical measurements, laboratory test results, and adverse event records collected throughout the trial period. Statistical analyses were conducted to assess non-inferiority between the two treatment groups. This dataset provides valuable insights for researchers interested in diabetes management, pharmacotherapy, and randomized controlled trials.</p>

opencc-by-4.0Nov 2024View details →
zenodo32/100

Statistical analysis of the efficacy of the decontamination treatment

<p>This model was developed and applied by the EFSA Working Group on Working Group on the evaluation of substances used to remove microbial contamination from product of animal origin during the preparatory work on the Scientific Opinion &lsquo;Evaluation of the safety and efficacy of the organic acids lactic and acetic acids to reduce microbiological surface contamination on pork carcasses and pork cuts&#39;&nbsp;(see http://doi.org/10.2903/j.efsa.2018.5482).</p> <p>The code (SAS&nbsp;and R) has been used to evaluate the efficacy of two organic acids, lactic and acetic acid, intended to be used individually by food business operators during processing to reduce microbiological surface contamination on carcasses and cuts from pork. The reduction is expressed as log<sub>10</sub> reduction, i.e. the difference between the means of the log<sub>10</sub> concentrations of control group and treated group and corresponding 95% confidence interval (95% CI) when this information was available.</p> <p>&nbsp;</p> <p>The code may be run using these files:</p> <p>- data extraction from the file&#39;<em>data_20181010.xlsx</em> &#39;</p> <p>- References list using the file &#39;<em>references_20180719.xlsx </em>&#39;</p> <p>- Appraisal scores using the&nbsp;file &#39;<em>Appraisal_20181004.xlsx </em>&#39;</p> <p>&nbsp;</p>

opencc-by-4.0Dec 2018View details →
dryad32/100

Large carnivore conservation and traditional pastoralism: An economic analysis on the efficacy of bear-reindeer predation mitigation measures: Dataset for 2014–2016 corralling versus forest treatment analysis

<p>While wildlife and cultural preservation goals can be either complimentary or counteractive, the goals of large carnivore conservation and traditional pastoralist lifestyles are often at odds.  Livestock depredation can negatively impact the economies of livestock herders, while subsequent lethal removals contribute to local carnivore population declines. Here, we collaborated with two Sámi reindeer herding communities (2010–2016) situated in Sweden's boreal forest to evaluate the efficacy and economic feasibility of three brown bear predation mitigation measures: corralling pregnant reindeer during parturition, lethal bear management removals, and public bear-license hunting. Calving corrals increased survival for reindeer calves born to average-sized females by 7% to 15% and by 14% to 30% for calves born to small females. However, the realized cost of implementing calving corrals outweighed the financial gain for both our study areas (net losses ranged between €1,111 and €6,210 per calf saved from bear predation per year when using the updated 2021 calf value), as well as for almost every theoretical scenario we explored (net losses €234 and €13,995 per calf saved from bear predation). The exception was the theoretical scenario where small herding communities overlapped large bear populations, which crossed the breakeven efficacy bear/reindeer ratio of 13.5 bears/100 reindeer and had a potential net gain of €36 per saved calf. Similarly, the cost of lethal management removals of bears also outweighed the potential financial gain from saved calves, with net losses between €75 and €239 per calf. License hunting, where the hunters voluntarily incur the monetary costs of removing bears, is in most cases the only economically viable mitigation measure where the cost of mitigation did not outweigh the financial gain from increased reindeer survival. While the annual public license hunt was the most cost-effective mitigation measure, it may be less biologically effective, i.e., bear hunting occurs in the fall and reindeer parturition the following spring which leaves time for the empty niche of harvested bears to be filled by survivors. Economically and biologically effective predation mitigation measures are key for promoting coexistence, and we suggest that potential mitigation measures should be studied in collaboration with local people.</p>

opencc-zeroMay 2023View details →
ClinicalTrials.gov32/100

Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy

ClinicalTrials.gov study NCT02814110. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance

ClinicalTrials.gov study NCT04781023. IPD Sharing: NO. Countries: 1. Publications: 7.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov32/100

Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-

ClinicalTrials.gov study NCT02613403. IPD Sharing: YES. Countries: 0. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov32/100

Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis

ClinicalTrials.gov study NCT03736161. IPD Sharing: NO. Countries: 1. Publications: 32.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.